Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Capillary growth, ultrastructure remodelling and exercise training in skeletal muscle of essential hypertensive patients.

Acta physiologica (Oxford, England)·2015
Same author

Endogenous α-calcitonin-gene-related peptide promotes exercise-induced, physiological heart hypertrophy in mice.

Acta physiologica (Oxford, England)·2014
Same author

Effects of eccentric cycle ergometry in alpine skiers.

International journal of sports medicine·2010
Same author

Training in hypoxia and its effects on skeletal muscle tissue.

Scandinavian journal of medicine & science in sports·2008
Same author

Acetyl-L-carnitine feeding to unloaded rats triggers in soleus muscle the coordinated expression of genes involved in mitochondrial biogenesis.

Biochimica et biophysica acta·2006
Same author

Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.

The Journal of pathology·2006

Related Experiment Video

Updated: May 11, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

Left ventricular systolic function in aortic stenosis.

H P Krayenbuehl1, O M Hess, M Ritter

  • 1Division of Cardiology, University Hospital, Zürich, Switzerland.

European Heart Journal
|April 1, 1988
PubMed
Summary
This summary is machine-generated.

In aortic valve stenosis, left ventricular hypertrophy can be inadequate, leading to increased wall stress. This, along with reduced contractility, can lower ejection fraction, impacting patient outcomes.

More Related Videos

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
04:48

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery

Published on: November 28, 2018

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
08:09

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats

Published on: December 13, 2019

Related Experiment Videos

Last Updated: May 11, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
04:48

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery

Published on: November 28, 2018

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
08:09

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats

Published on: December 13, 2019

Area of Science:

  • Cardiology
  • Cardiovascular Physiology

Background:

  • Aortic valve stenosis (AVS) causes concentric left ventricular (LV) hypertrophy.
  • Hypertrophy is considered appropriate when the radius-to-wall thickness ratio (r/h) and LV systolic pressure product remain constant, indicating normal wall stress.

Purpose of the Study:

  • To investigate the relationship between LV hypertrophy, ejection fraction, and outcomes in aortic valve stenosis.
  • To determine if ejection fraction is a reliable indicator of systolic myocardial function and a predictor of postoperative survival.

Main Methods:

  • Literature review of 23 studies examining LV angiographic mass, ejection fraction, and myocardial structure.
  • Analysis of preoperative LV angiographic mass and end-systolic volume as predictors of postoperative outcomes.

Main Results:

  • An increased (r/h) x LV systolic pressure product signals inadequate LV hypertrophy and increased wall stress.
  • An inverse relationship (r = -0.59) exists between ejection fraction and LV angiographic mass.
  • Normal ejection fraction may be maintained by preload reserve despite reduced contractility.
  • Myocardial structure analysis showed no differences between normal and depressed ejection fraction groups.
  • Markedly increased preoperative LV mass and end-systolic volume predict poor postoperative outcomes.

Conclusions:

  • Inadequate LV hypertrophy and reduced contractility can depress ejection fraction in AVS.
  • Preoperative ejection fraction is a poor predictor of survival; LV mass and end-systolic volume are better indicators of prognosis.